advertisement
Li Q 54
Showing records 1 to 25 | Display all abstracts from Li Q126416 Social, personal and medical factors influencing treatment delay for patients with primary glaucoma during the COVID-19 pandemic: a qualitative interview study
Liu H
BMJ open 2025; 15: e096469
126367 Evaluation of the Iris Vessel Density for Primary Glaucoma Diagnosis Using Anterior Segment Optical Coherence Tomography
Li Q
Ophthalmic Research 2025; 68: 320-332
125437 A water-soluble drug nanoparticle-loaded in situ gel for enhanced precorneal retention and its transduction mechanism of pharmacodynamic effects
Zhang Y
International Journal of Pharmaceutics 2025; 670: 125150
126859 Enhanced ocular retention and intraocular pressure-lowering efficacy of hydrophobic microspheres for glaucoma treatment
Li Q
Colloids and surfaces. B, Biointerfaces 2025; 252: 114659
126623 Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Zhang D
Experimental Eye Research 2025; 255: 110352
126367 Evaluation of the Iris Vessel Density for Primary Glaucoma Diagnosis Using Anterior Segment Optical Coherence Tomography
Wu W
Ophthalmic Research 2025; 68: 320-332
125437 A water-soluble drug nanoparticle-loaded in situ gel for enhanced precorneal retention and its transduction mechanism of pharmacodynamic effects
Xiao Z
International Journal of Pharmaceutics 2025; 670: 125150
126859 Enhanced ocular retention and intraocular pressure-lowering efficacy of hydrophobic microspheres for glaucoma treatment
Pan B
Colloids and surfaces. B, Biointerfaces 2025; 252: 114659
126623 Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Hu F
Experimental Eye Research 2025; 255: 110352
126416 Social, personal and medical factors influencing treatment delay for patients with primary glaucoma during the COVID-19 pandemic: a qualitative interview study
Sun L
BMJ open 2025; 15: e096469
126859 Enhanced ocular retention and intraocular pressure-lowering efficacy of hydrophobic microspheres for glaucoma treatment
Pan K
Colloids and surfaces. B, Biointerfaces 2025; 252: 114659
126623 Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Li T
Experimental Eye Research 2025; 255: 110352
126416 Social, personal and medical factors influencing treatment delay for patients with primary glaucoma during the COVID-19 pandemic: a qualitative interview study
Li Y
BMJ open 2025; 15: e096469
126367 Evaluation of the Iris Vessel Density for Primary Glaucoma Diagnosis Using Anterior Segment Optical Coherence Tomography
Man X
Ophthalmic Research 2025; 68: 320-332
125437 A water-soluble drug nanoparticle-loaded in situ gel for enhanced precorneal retention and its transduction mechanism of pharmacodynamic effects
Li Q
International Journal of Pharmaceutics 2025; 670: 125150
126416 Social, personal and medical factors influencing treatment delay for patients with primary glaucoma during the COVID-19 pandemic: a qualitative interview study
Liu W
BMJ open 2025; 15: e096469
126367 Evaluation of the Iris Vessel Density for Primary Glaucoma Diagnosis Using Anterior Segment Optical Coherence Tomography
Dai C
Ophthalmic Research 2025; 68: 320-332
125437 A water-soluble drug nanoparticle-loaded in situ gel for enhanced precorneal retention and its transduction mechanism of pharmacodynamic effects
Ke Y
International Journal of Pharmaceutics 2025; 670: 125150
126859 Enhanced ocular retention and intraocular pressure-lowering efficacy of hydrophobic microspheres for glaucoma treatment
Zhang Y
Colloids and surfaces. B, Biointerfaces 2025; 252: 114659
126623 Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Liu H
Experimental Eye Research 2025; 255: 110352
125437 A water-soluble drug nanoparticle-loaded in situ gel for enhanced precorneal retention and its transduction mechanism of pharmacodynamic effects
Gu X
International Journal of Pharmaceutics 2025; 670: 125150
126859 Enhanced ocular retention and intraocular pressure-lowering efficacy of hydrophobic microspheres for glaucoma treatment
Rupenthal ID
Colloids and surfaces. B, Biointerfaces 2025; 252: 114659
126623 Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Li Q
Experimental Eye Research 2025; 255: 110352
126416 Social, personal and medical factors influencing treatment delay for patients with primary glaucoma during the COVID-19 pandemic: a qualitative interview study
Bu S
BMJ open 2025; 15: e096469
126859 Enhanced ocular retention and intraocular pressure-lowering efficacy of hydrophobic microspheres for glaucoma treatment
Liu L
Colloids and surfaces. B, Biointerfaces 2025; 252: 114659
